Free Trial
NYSE:RELX

Relx (RELX) Stock Price, News & Analysis

$46.54
+0.54 (+1.17%)
(As of 07/26/2024 ET)
Today's Range
$46.28
$46.73
50-Day Range
$43.35
$46.54
52-Week Range
$31.38
$46.73
Volume
668,631 shs
Average Volume
930,655 shs
Market Capitalization
$86.95 billion
P/E Ratio
N/A
Dividend Yield
2.30%
Price Target
N/A

Relx MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.11% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.65mentions of Relx in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
10.97%
From $1.55 to $1.72 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.70 out of 5 stars

Computer And Technology Sector

486th out of 612 stocks

Business Services, Not Elsewhere Classified Industry

79th out of 93 stocks

RELX stock logo

About Relx Stock (NYSE:RELX)

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and data sets that help researchers and healthcare professionals to advance science and health outcomes. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

RELX Stock Price History

RELX Stock News Headlines

Is RELX PLC's (LON:REL) 52% ROE Better Than Average?
Obama wins Presidential debate
When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.”
RELX PLC (RELX) Q2 2024 Earnings Call Transcript
RELX rises Monday, outperforms market
RELX falls Friday, still outperforms market
Obama wins Presidential debate
When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.”
See More Headlines
Receive RELX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Relx and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 6/18 Dividend
5/02/2024
Dividend Payable
6/18/2024
Today
7/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
Business Services
Employees
36,500
Year Founded
1993

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$9.91 billion
Cash Flow
$1.83 per share
Book Value
$2.27 per share

Miscellaneous

Outstanding Shares
1,868,200,000
Free Float
1,867,645,000
Market Cap
$87.23 billion
Optionable
Optionable
Beta
0.89

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Erik Engstrom M.Sc Econ (Age 61)
    M.Sc Eng., MBA, CEO & Executive Director
    Comp: $5.07M
  • Mr. Nicholas Lawrence LuffMr. Nicholas Lawrence Luff (Age 57)
    CFO & Executive Director
    Comp: $2.95M
  • Ms. Kumsal Bayazit Besson (Age 50)
    Chief Executive Officer of Scientific, Technical & Medical
  • Mr. Colin Tennant
    Head of Investor Relations
  • Mr. Henry Adam Udow (Age 66)
    Chief Legal Officer & Company Secretary
  • Mr. Paul Abrahams
    Head of Corporate Communications
  • Ms. Rosemary Thomson (Age 55)
    Chief Human Resources Officer
  • Mr. Mark Kelsey
    Chief Executive Officer of Risk
  • Ms. Jelena Sevo
    Chief Strategy Officer
  • Mr. Michael Walsh
    Chief Executive Officer of Legal

Should I Buy Relx Stock? RELX Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Relx Plc:

  • Relx Plc shares hit a new 52-week high at $46.11, indicating positive momentum and potential for further growth.
  • Relx has a debt-to-equity ratio of 1.51, which suggests a balanced approach to financing operations.
  • Institutional investors like Capital International Investors and Goldman Sachs Group Inc. have been increasing their stakes in Relx, indicating confidence in the company's future performance.
  • Relx operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions, providing diversified revenue streams and reducing dependency on a single market.
  • The company's 50-day and 200-day moving averages show a positive trend, reflecting consistent growth in the stock price over recent periods.

Cons

Investors should be bearish about investing in Relx Plc for these reasons:

  • Relx stock traded down 1.9% recently, indicating short-term volatility that may pose risks to investors.
  • The company's current ratio of 0.52 and quick ratio of 0.47 suggest potential liquidity challenges in meeting short-term obligations.
  • Analysts from StockNews.com recently downgraded Relx from a "buy" to a "hold" rating, signaling a potential slowdown in growth prospects.
  • While some institutional investors are increasing their stakes, others like Frazier Financial Advisors LLC have bought new positions in Relx, which may indicate mixed sentiments among investors.
  • Relx's 12-month high of $46.65 may pose resistance levels for further stock price appreciation, potentially limiting short-term gains for investors.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, July 22, 2024. Please send any questions or comments about these Relx pros and cons to contact@marketbeat.com.

RELX Stock Analysis - Frequently Asked Questions

How have RELX shares performed this year?

Relx's stock was trading at $39.66 at the beginning of 2024. Since then, RELX shares have increased by 17.3% and is now trading at $46.54.
View the best growth stocks for 2024 here
.

Who are Relx's major shareholders?

Relx's top institutional investors include Raymond James & Associates (0.05%), Bank of New York Mellon Corp (0.02%), Eagle Ridge Investment Management (0.02%) and QRG Capital Management Inc. (0.01%).

How do I buy shares of Relx?

Shares of RELX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Relx own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Relx investors own include Intel (INTC), NVIDIA (NVDA), Alibaba Group (BABA), JPMorgan Chase & Co. (JPM), Pfizer (PFE), Verizon Communications (VZ) and AbbVie (ABBV).

This page (NYSE:RELX) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners